Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × Vorinostat × 1 year × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 4 Leukemia, Myeloid, Acute 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroblastoma 3 Lymphoma, Large B-Cell, Diffuse 3 Brain Neoplasms 3 Recurrence 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia 2 Glioblastoma 2 Breast Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Prostatic Neoplasms 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Ototoxicity 1 Oligodendroglioma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell 1

Interventions

Specimen Handling 8 Tamoxifen 7 Radiotherapy 5 exemestane 3 Radiation 3 Letrozole 3 Anastrozole 3 Surveys and Questionnaires 2 Sentinel Lymph Node Biopsy 2 Radiation Dose Hypofractionation 2 Patient Navigation 2 Observation 2 Metformin 2 Mastectomy 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 trastuzumab biosimilar HLX02 1 poly ICLC 1 palbociclib 1 fezolinetant 1 elacestrant 1 afimoxifene 1 abemaciclib 1 Trastuzumab 1 Testosterone 1 Tablets 1 Surgical Procedures, Operative 1 Steroids 1 Standard of Care 1 Selective Estrogen Receptor Modulators 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡